Skip to main content
See every side of every news story
Published loading...Updated

Near Another Therapeutic Option for Diabetic Foot Ulcer

SANTA CLARA, Villa Clara. — A phase III clinical trial to evaluate the efficacy and safety of ointment Dermofural 0.15 percent as an antibacterial in adult patients with mild infection in diabetic foot ulcers has been carried out since last May in the Clinical-Surgical Hospital Arnaldo Milián Castro and in the six polyclinics of the provincial capital. It is a product with a Villaclarian seal, since its active pharmaceutical ingredient (furvina)…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.Cross Cancel Icon

1 Articles

SANTA CLARA, Villa Clara. — A phase III clinical trial to evaluate the efficacy and safety of ointment Dermofural 0.15 percent as an antibacterial in adult patients with mild infection in diabetic foot ulcers has been carried out since last May in the Clinical-Surgical Hospital Arnaldo Milián Castro and in the six polyclinics of the provincial capital. It is a product with a Villaclarian seal, since its active pharmaceutical ingredient (furvina)…

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

juventudrebelde.cu broke the news in on Monday, January 26, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal